Epa Vs Dha — Which Omega-3 Matters More For Your Brain?
Quick Read EPA and DHA are two different omega-3 fatty acids found in fish oil, and they work differently in
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
Ashwagandha, an herb used in traditional medicine for over 3,000 years, shows measurable effects on memory and thinking in clinical trials with real people. Multiple studies found that people taking ashwagandha improved on memory tests, reaction time, and focus compared to those taking placebo. The improvements appeared strongest in people with mild memory problems, but also showed up in stressed healthy adults and younger people.
The herb appears to work through several pathways: it lowers cortisol (a stress hormone that damages the memory centre of the brain), reduces inflammation, and may protect nerve cells. Most studies used doses between 225 and 400 mg daily and found the supplement safe with minimal side effects. However, the studies used small groups of people (typically 40 to 125 participants) and lasted only 30 to 90 days, so we need larger and longer trials before calling these findings definitive.
If you’re noticing your memory feels slower with age, struggling with focus under stress, or want to support your brain health, ashwagandha is one of the more evidence-backed supplement options available. It works best when combined with other brain-supporting habits like sleep and stress management.
Verdict: Ashwagandha shows promising, consistent evidence for modest memory and cognitive improvements in clinical trials, particularly for people with mild cognitive decline or high stress, though larger long-term studies are still needed.
What if one of the most promising memory supplements available today had been hiding in plain sight for over 3,000 years, buried in Ayurvedic texts while Western medicine was busy looking elsewhere? Most people who’ve heard of ashwagandha associate it with stress relief or gym performance. And yes, it does both of those things rather well. But there’s a quieter, more compelling story emerging from the clinical trial data: ashwagandha appears to have a meaningful, measurable effect on human memory, particularly working memory, recall, and information-processing speed. Not in mice. Not in petri dishes. In actual randomised, double-blind, placebo-controlled trials involving real people. To build this picture, Vitacuity analysed over 1.77 million research papers and selected the most relevant studies on this topic. Here’s what the evidence genuinely shows, and where the gaps still are.
Before we get into the trial data, it’s worth understanding *why* ashwagandha might influence memory at all. The herb, formally known as *Withania somnifera*, is classified in Ayurvedic medicine as a *Rasayana*, meaning a rejuvenator or tonic. Its active compounds are primarily withanolides, a family of naturally occurring steroidal lactones that appear to influence several brain-relevant biological pathways [12].
Here are the mechanisms that researchers believe are at work:
Cortisol and the stress-memory connection. Chronic stress raises cortisol, and chronically elevated cortisol damages the hippocampus, the brain region most central to forming and retrieving memories. Ashwagandha appears to reduce circulating cortisol levels, which may indirectly protect memory by lowering this hormonal assault on the brain [9].
Neuroinflammation. One of the hallmarks of cognitive ageing is *inflammaging*, low-grade, chronic inflammation that gradually damages neural tissue. Ashwagandha has demonstrated anti-inflammatory effects in clinical studies, including reductions in C-reactive protein, which may help protect neurons over time [2].
Neuroprotection and neuroplasticity. Animal studies suggest withanolides may promote the growth of dendrites, the branching extensions that allow neurons to communicate with each other, and may protect against the kind of neural damage seen in Alzheimer’s and Parkinson’s disease [12]. These are preclinical findings, so we shouldn’t over-extrapolate, but they give biological credibility to the human trial results.
Telomerase activity. One 2025 review noted evidence that ashwagandha may enhance telomerase activity, the enzyme that helps maintain the protective caps on chromosomes, suggesting a potential role in cellular longevity at the neurological level [2]. This is early-stage science but a genuinely interesting mechanistic thread.
In short: ashwagandha doesn’t just sit on one dial. It appears to nudge several dials simultaneously, stress hormones, inflammation, neural structure, in ways that cumulatively might support a brain that works better for longer.
Evidence grade: Promising, multiple small RCTs, consistent findings, but sample sizes are modest
The most clinically significant research focuses on adults with *mild cognitive impairment* (MCI), people who are experiencing memory and thinking problems beyond what’s expected for their age, but who haven’t crossed the threshold into dementia. This is arguably the most important population to study, because MCI represents the window where intervention might actually matter.
A 2025 randomised, double-blind, placebo-controlled pilot study tested a standardised ashwagandha extract called Somin-On™ in 40 adults with MCI. Participants received either 250 mg daily or a placebo for 60 days. Memory was assessed using four validated tools: the Montreal Cognitive Assessment (MoCA), the Mini-Mental State Examination (MMSE), the Wechsler Memory Scale-III (WMS-III), and the Shepard Mental Rotation Task [1].
The results were striking for a 60-day trial. On the Shepard Mental Rotation test, a measure of visuospatial processing, scores rose by 12.22% at 30 days and 31.67% at 60 days from baseline in the ashwagandha group. MoCA scores improved by 7.83% at 30 days and 14.77% at 60 days. MMSE scores improved by 9.26% at 30 days and 19.21% at 60 days. The ashwagandha group outperformed the placebo group across immediate memory, general memory, and working memory [1].
The caveat? Forty participants is a pilot study. These are directionally impressive results, but they need replication in larger trials before we can call them definitive.
Evidence grade: Promising, one larger RCT (n=125), 90-day duration, validated neuropsychological testing
Not everyone experiencing cognitive strain has a clinical diagnosis. Stress, the everyday, modern kind, appears to quietly erode memory function too. A randomised, double-blind, placebo-controlled study enrolled 130 healthy cognitively-sound adults aged 20–55 and gave them either ashwagandha SR (sustained release) or a placebo once daily for 90 days. 125 participants completed the trial [14].
Memory was assessed using the Cambridge Neuropsychological Test Automated Battery (CANTAB), a rigorous, computerised testing platform. The results showed significantly improved recall memory in the ashwagandha group. Specifically, first-attempt memory scores were 12.9 ± 6.7 in the ashwagandha group versus 10.1 ± 6.3 in the placebo group. Total errors in recalling patterns were substantially lower: 17.5 ± 23.3 in the ashwagandha group versus 27.7 ± 23.6 in the placebo group. Perceived stress scores also dropped significantly (13.0 ± 5.0 vs. 18.7 ± 4.6) [14].
This study matters because it used a much larger sample than the MCI pilot, ran for 90 days, and used a validated battery rather than self-report. The combination of improved memory *and* reduced stress in the same trial also makes mechanistic sense, it’s hard to know whether the memory improvement came from less cortisol, better sleep, or direct neurological effects, and it’s probably all three.
Evidence grade: Promising, small crossover RCT (n=13), rigorous design but very small sample
This is where ashwagandha starts to get interesting from a different angle. Most nootropic supplements are thought to require weeks of loading before effects emerge. But a 2022 crossover study tested what happens when healthy volunteers take a single 400 mg dose of ashwagandha extract (NooGandha®) [8].
Thirteen participants completed the double-blind, placebo-controlled crossover design, performing cognitive tests before and after taking either ashwagandha or a placebo. The Sternberg Task, which measures working memory, showed improved reaction times at 3 and 6 hours post-ingestion. On the Psychomotor Vigilance Task, ashwagandha helped sustain attention and prevent the mental fatigue-driven increase in reaction times seen in the placebo group. On the Go/No-Go test, ashwagandha promoted faster response times, suggesting reduced mental fatigue [8].
The honest caveat here is the sample size: 13 people is extremely small. Crossover designs are methodologically sound, but we’d want to see this replicated with far more participants before drawing strong conclusions. That said, the direction of the findings is consistent with the rest of the trial literature.
Evidence grade: Promising, RCT (n=60), 30 days, two doses tested
A 2022 randomised, double-blind study enrolled 60 healthy adults (43 women, 17 men, mean age 34.4 years) who reported experiencing perceived stress. Participants were assigned to one of three groups: ashwagandha at 400 mg/day, ashwagandha at 225 mg/day, or placebo, for 30 days. Cognition was assessed using CNS Vital Signs, a validated computerised cognitive test [9].
Both ashwagandha groups showed significant improvements in cognitive flexibility, visual memory, reaction time, psychomotor speed, and executive function compared to placebo. Cortisol levels fell over time in both ashwagandha groups, with statistically significant reductions in the 225 mg/day group. The placebo group showed a non-significant *increase* in cortisol over the same period [9].
What makes this finding particularly useful is the dose comparison: 225 mg and 400 mg both performed well, suggesting that you don’t necessarily need to maximise the dose to see cognitive benefits. No adverse events were reported in either ashwagandha group.
Evidence grade: Promising, RCT (n=59), 30 days, multiple cognitive domains tested
Most of the research on cognitive supplements understandably focuses on older adults. But a 2024 study examined whether ashwagandha offers cognitive benefits in younger, healthy individuals aged 18–35. Fifty-nine men and women were randomised in a double-blind design to receive either 225 mg of liposomal ashwagandha or a placebo for 30 days, with cognitive assessments at baseline and follow-up using the COMPASS battery [11].
The ashwagandha group showed improvements across multiple domains: word recall (both correct answers and recalled attempts), choice reaction time, picture recognition (correct responses and reaction time), digit vigilance, and Stroop Color-Word performance, a measure of executive function and attention. Mood measures also shifted favourably, with reductions in tension and fatigue scores [11].
This is significant because it suggests ashwagandha’s cognitive effects aren’t purely a function of correcting stress-driven impairment in older or clinically compromised populations. There appear to be benefits even in healthy younger brains, though the sample is still relatively small at 59 participants.
Evidence grade: Promising, systematic review of five RCTs, heterogeneous populations
A 2020 systematic review searched PubMed, EMBASE, Medline, PsycINFO and ClinicalTrials.gov to identify all clinical trials examining ashwagandha and cognitive function. Five studies met the eligibility criteria [7].
The review found that across all five trials, despite differences in populations (including older adults with MCI and adults with psychiatric conditions such as schizophrenia and bipolar disorder), doses, and durations, ashwagandha extract consistently improved performance on cognitive tasks, executive function, attention, and reaction time. The herb was well tolerated in all trials, with good adherence and minimal side effects [7].
The important caveat the reviewers raised: the study populations were heterogeneous, meaning it’s difficult to draw clean universal conclusions. Someone with schizophrenia and someone with age-related MCI may be experiencing cognitive difficulties through entirely different mechanisms. But the consistency of the *direction* of findings across these varied populations is notable, and arguably increases rather than decreases our confidence in the biological plausibility of the effect.
Evidence grade: Promising, multiple trials, consistent cortisol-reduction findings
One recurring thread across the ashwagandha trial literature is the cortisol connection. Multiple studies [9] [14] have documented significant reductions in salivary and serum cortisol with regular ashwagandha supplementation. A 2025 comprehensive review of ashwagandha’s geroprotective effects highlighted this as one of several mechanisms through which the herb may support healthy cognitive ageing [2].
The relevance for memory is direct: the hippocampus, which is central to memory formation and retrieval, is densely packed with cortisol receptors. Prolonged exposure to high cortisol damages hippocampal neurons. Lowering cortisol, even modestly, may therefore protect memory-relevant brain tissue over time. This is a plausible, biologically coherent mechanism that bridges the anti-stress effects and the memory effects observed in trials [2] [12].
A 2024 study assessing ashwagandha root extract in adults with self-reported cognitive and energy problems also reported improvements in memory and executive function alongside mood and fatigue measures, further supporting the idea that the cognitive and psychological effects of ashwagandha are intertwined rather than separate [15].
Let’s be honest about the gaps, because there are real ones.
Sample sizes are small. The most rigorous trials in this space, particularly those on MCI, involve 40 to 60 participants. That’s enough to generate a meaningful signal, but nowhere near enough to be confident we’re not seeing a statistical quirk. We need trials with hundreds of participants, not dozens.
Standardisation is a genuine problem. Multiple different ashwagandha extracts appear across these studies, Somin-On™, NooGandha®, KSM-66, Sensoril, and others. Each is standardised to different withanolide concentrations or different parts of the plant (root vs. leaf vs. combined). When different extracts are used across trials, comparing results becomes complicated. The 2025 review of ashwagandha and healthy ageing explicitly calls for large-scale trials using standardised extracts to resolve this issue [2].
Long-term effects are unknown. The longest trial in this dataset ran for 90 days [14]. We simply don’t know what happens to memory outcomes, positive or negative, when ashwagandha is taken consistently over one, two, or five years. Most cognitive decline happens over decades, not months.
The stress-cognition question. Is ashwagandha improving memory *directly*, or is it improving memory *indirectly* by reducing stress and cortisol, which in turn allows the brain to function better? This distinction matters for understanding who might benefit most. Someone with high stress and stress-related cognitive fog may see a much larger benefit than someone who is already calm and well-rested.
Healthy adults vs. clinical populations. The strongest, most clinically meaningful findings come from the MCI studies. Effects in healthy, younger adults are real but smaller and harder to interpret. A 10% improvement on a working memory test may not translate into a noticeable difference in daily life for someone who was already functioning well.
The preclinical Alzheimer’s and Parkinson’s data are interesting, there are neuroprotective signals in animal models [2] [12], but we are a long way from being able to say ashwagandha prevents or slows neurodegenerative disease in humans.
Here’s how a sensible, well-informed friend would read all of this.
Ashwagandha is not a cure for memory loss and it won’t reverse dementia. But within the realistic scope of what a supplement can do for cognitive health, the evidence is genuinely encouraging, more so than for many supplements that are far more heavily marketed.
Multiple randomised, double-blind, placebo-controlled trials, albeit in small samples, consistently show improvements in working memory, recall, reaction time, and executive function. The effect appears across healthy stressed adults, people with mild cognitive impairment, and even healthy younger adults. The cognitive benefits align with a plausible biological mechanism (cortisol reduction, reduced neuroinflammation, potential neuroprotection), and the safety profile across all these trials is excellent, with no serious adverse events reported.
Who benefits most? Based on the current evidence, the clearest benefit appears to be in adults with: – Mild cognitive impairment [1] – High perceived stress (where cortisol-related cognitive impairment may be a factor) [9] [14] – Subjective cognitive and energy problems [15]
If you’re in your 40s, 50s or 60s, noticing that your memory feels a little slower, struggling with focus under pressure, or simply want to do what you reasonably can to support your brain as you age, ashwagandha is one of the more evidence-backed options available. The risk profile is low. The cost is low. The consistency of findings across multiple independent trials is reassuring.
On dosing: trials in this dataset have used doses ranging from 225 mg to 400 mg daily [8] [9] [11], with the 250–300 mg range also showing significant effects in the MCI trial [1]. There’s no compelling evidence from these studies that higher doses produce dramatically better cognitive outcomes, the 225 mg/day group in one study performed comparably to the 400 mg/day group [9].
A practical note on stress: if you’re taking ashwagandha primarily for memory support, anything you can do to address the stress side of the equation simultaneously, sleep, movement, managing workload, will likely amplify the benefit. The cortisol-hippocampus connection is well established, and ashwagandha appears to be working, at least in part, through that pathway.
The bottom line? The evidence is at a “promising” level, not yet strong enough to say “this definitely works for everyone,” but consistent enough that a thoughtful person with an interest in their cognitive health should take it seriously. We’ll be watching for the larger, longer-term trials that this field genuinely needs.
[1] Effect of ashwagandha (Withania somnifera) extract standardized with Sominone (Somin-On™) on memory and cognitive function in adults with mild cognitive impairment: a randomized double-blind, placebo-controlled pilot study (2025). DOI: 10.1177/02698811251324377 | https://pubmed.ncbi.nlm.nih.gov/40099725/
[2] Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits (2025). DOI: 10.1007/s10522-025-10320-0 | https://pubmed.ncbi.nlm.nih.gov/40921883/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12417257/
[3] Ashwagandha (Withania somnifera): mental health, sleep quality, cognitive function, anxiety, stress and fatigue, a review (2025). DOI: 10.3390/nu17132143 | https://pubmed.ncbi.nlm.nih.gov/40647248/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12252077/
[7] A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction (2020). DOI: 10.1002/ptr.6552 | https://pubmed.ncbi.nlm.nih.gov/31742775/
[8] Effects of Acute Ashwagandha Ingestion on Cognitive Function (2022). DOI: 10.3390/ijerph191911852 | https://pubmed.ncbi.nlm.nih.gov/36231152/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565281/
[9] Efficacy of Withania somnifera supplementation on adult’s cognition and mood (2022). DOI: 10.1016/j.jaim.2021.08.003 | https://pubmed.ncbi.nlm.nih.gov/34838432/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728079/
[11] Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood (2024). DOI: 10.3390/nu16121813 | https://pubmed.ncbi.nlm.nih.gov/38931168/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11207027/
[12] An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda (2011). https://pubmed.ncbi.nlm.nih.gov/22754076/
[14] Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study (2021). DOI: 10.1155/2021/8254344 | https://pubmed.ncbi.nlm.nih.gov/34858513/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632422/
[15] Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study (2024). DOI: 10.1080/02791072.2024.2424279 | https://pubmed.ncbi.nlm.nih.gov/39498904/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read EPA and DHA are two different omega-3 fatty acids found in fish oil, and they work differently in
Quick Read CoQ10 is a molecule your body naturally produces that helps cells generate energy, particularly in your brain. Your
